Botulinum toxin type <scp>A</scp> for the treatment of non‐neurogenic overactive bladder: does using onabotulinumtoxin <scp>A</scp> ( <scp>B</scp> otox ^® ) or abobotulinumtoxin <scp>A</scp> ( <scp>D</scp> ysport ^® ) make a difference?

Abstract

AbobotulinumtoxinA use was complicated by a significantly higher risk of requiring ISC. The study suggests that these two toxins are not interchangeable at the doses used.